Patents by Inventor Jens Marcel Van Roey

Jens Marcel Van Roey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200345733
    Abstract: The present invention concerns the microbicidal activity of certain pyrimidine or triazine containing non-nucleoside reverse transcriptase inhibitors. The compounds of the present invention inhibit the systemic infection of a human being with HIV, in particular, the present compounds prevent sexual HIV transmission in humans.
    Type: Application
    Filed: July 16, 2020
    Publication date: November 5, 2020
    Inventors: Jens Marcel Van Roey, Marie-Pierre T.M.M.G. De Bethune, Paul Stoffels
  • Publication number: 20170100399
    Abstract: The present invention concerns the microbicidal activity of certain pyrimidine or triazine containing non-nucleoside reverse transcriptase inhibitors.
    Type: Application
    Filed: December 23, 2016
    Publication date: April 13, 2017
    Inventors: Jens Marcel Van Roey, Marie-Pierre T.M.M.G. De Bethune, Paul Stoffels
  • Publication number: 20110165093
    Abstract: The present invention concerns the microbicidal activity of certain pyrimidine or triazine containing non-nucleoside reverse transcriptase inhibitors. The compounds of the present invention inhibit the systemic infection of a human being with HIV, in particular, the present compounds prevent sexual HIV transmission in humans.
    Type: Application
    Filed: March 8, 2011
    Publication date: July 7, 2011
    Applicant: TIBOTEC PHARMACEUTICALS LTD.
    Inventors: Jens (Marcel) Van Roey, Marie-Pierre T.M.M.G. De Bethune, Paul Stoffels
  • Patent number: 7935710
    Abstract: The present invention concerns the microbicidal activity of certain pyrimidine or triazine containing non-nucleoside reverse transcriptase inhibitors. The compounds of the present invention inhibit the systemic infection of a human being with HIV, in particular, the present compounds prevent sexual HIV transmission in humans.
    Type: Grant
    Filed: May 13, 2003
    Date of Patent: May 3, 2011
    Assignee: Tibotec Pharmaceuticals Ltd.
    Inventors: Jens Marcel Van Roey, Marie-Pierre T.M. M. G. De Bethune, Paul Stoffels